Genfit Stock

Genfit EBIT per Employee

The EBIT per Employee of Genfit (GNFT.PA) as of Aug 5, 2026 is 18,428.57 EUR. In the previous year, EBIT per Employee was -152,348.57 EUR — a change of -112.10% (higher).

EBIT per Employee

18,428.57EUR

YoY

-112.10%

Last updated:

EBIT per Employee of Genfit is 2026 18,428.57 EUR. EBIT per Employee of Genfit was 2025 -152,348.57 EUR. It decreases by -112.10% higher compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

EBIT per Employee of Genfit is 18,428.57 EUR in 2026.

EBIT per Employee of Genfit changed from -152,348.57 EUR to 18,428.57 EUR, representing a -112.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Genfit since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Genfit historically and in real time.

Access this data via the Eulerpool API

Workforce — Genfit

All Key Metrics — Genfit